About A4Cell
A4Cell is a Healthcare company based in Madrid (Spain) founded in 2018. Live single cells are monitored and studied with specialized tools. A4Cell has raised $5.4 million across 4 funding rounds from investors including European Union, BeAble Capital and Dreavent Capital. Its chief executive, as recorded, is Elena Rivas. A4Cell offers products and services including CytoCHECK SPAchip® pH green Single-Detection Kit, CytoCHECK SPAchip® Calcium Single-Detection Kit, CytoCHECK SPAchip® OHrad ROS Single-Detection Kit, and CytoTRACK SPAchip® pH Dual-Detection Kit. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Cell Biology. Its legal entity is Arrays for Cell Nanodevices S.L.
Company details
A4Cell was established in 2018 in Madrid, Spain, within the biotechnology sector. Tools for examining live single cells are developed, including the SPAchip Technology. Cell behavior, physiology, and biomolecular interactions are analyzed through this approach. Responses from individual cells are tracked over extended periods. Research applications in cell monitoring are supported across operations.
- Headquarters Madrid, Spain
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website a4cell.com
- Social LinkedIn Instagram YouTube
- Legal Name Arrays For Cell Nanodevices S.L.
- Total Equity Funding$5.4M (USD)
in 4 rounds
- Latest Funding Round$3.26M (USD), Series B
Nov 2023
- InvestorsEuropean Union
& 4 more
Products & Services of A4Cell
A4Cell offers a comprehensive portfolio of products and services, including CytoCHECK SPAchip® pH green Single-Detection Kit, CytoCHECK SPAchip® Calcium Single-Detection Kit, CytoCHECK SPAchip® OHrad ROS Single-Detection Kit, and CytoTRACK SPAchip® pH Dual-Detection Kit.
Monitors intracellular pH in living cells for real-time analysis.
Enables calcium monitoring in cellular signaling pathways.
Detects reactive oxygen species in cells for research purposes.
Facilitates dual pH monitoring in cellular processes.
Apps and channels of A4Cell
its YouTube channel A4Cell Nanodevices has 2 subscribers and 3 videos.
Videos from A4Cell
The most watched videos on A4Cell's YouTube channel, A4Cell Nanodevices (2 subscribers). Click a video to play it here.
More on A4Cell Nanodevices.
Funding Insights of A4Cell
A4Cell has successfully raised a total of $5.4M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $3.26 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.4M
- Total Rounds 4
- Last Round Series B — $3.26M
- First Round $728,748
(Apr 2019)
- Investors Count 5
All 4 funding rounds of A4Cell with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2023 | $3.26M | Series B | – | Dreavent | |
| Apr 2022 | $747,163 | Grant | – | – | |
| Dec 2021 | $1.41M | Series A | – | – | |
| Apr 2019 | $728,748 | Seed | – | BeAble Capital | – |
5 investors in total: 5 institutional.
Investors in A4Cell
A4Cell has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, BeAble Capital and Dreavent Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Seed and early stage energy and tech focused VC firm investing primarily in Spain | 2008 | beablecapital.com | Madrid, Spain | |
Biotech investments are managed by Dreavent Capital for innovation. | dreaventcapital.com | Cambridge, United States | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
| innvierteeconomiasosteniblesiccsme.tcc.mode | ||||
| ideasdebomberossl.tcc.mode |
Investor details for A4Cell
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of A4Cell
7 people are tracked at A4Cell (4 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Elena Rivas | CEO | Leadership |
Alberto Hernandez | Chief Scientific Officer | Leadership |
Antonio Quílez-Álvarez | Head of Applications | Leadership |
María Bergua Estévez | COO | Leadership |
Laura Egea | Business Development | Team |
Marina Martínez Bartolomé, Ph.D. | Senior Scientist CRO | Team |
Irene Palacios Doiztúa | Tecnico Especialista Laboratorio CRO | Team |
Complete people profiles for A4Cell
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of A4Cell
3 dated milestones of A4Cell across 5 years, from founding to its latest funding, stage changes and deals.
- Founded A4Cell is founded.
- Funding First funding round of $729K.
- Funding Latest funding round, Series B, of $3.3M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about A4cell
Complete news archive for A4Cell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about A4Cell
A4Cell was founded in 2018 and raised its 1st funding round 1 year after it was founded.
A4Cell is headquartered in Madrid, Spain. It is registered at Madrid, Madrid, Spain.
Elena Rivas is the CEO of A4Cell, as recorded in our data.
A4Cell is a funded company, having raised a total of $5.4M across 4 funding rounds to date. The company's 1st funding round was a Seed of $728.75K, raised on Apr 2019.
A4Cell was established in 2018 in Madrid, Spain, within the biotechnology sector. Tools for examining live single cells are developed, including the SPAchip Technology. Cell behavior, physiology, and biomolecular interactions are analyzed through this approach. Responses from individual cells are tracked over extended periods. Research applications in cell monitoring are supported across operations.
A4Cell offers CytoCHECK SPAchip® pH green Single-Detection Kit, CytoCHECK SPAchip® Calcium Single-Detection Kit, CytoCHECK SPAchip® OHrad ROS Single-Detection Kit, and CytoTRACK SPAchip® pH Dual-Detection Kit.
A4Cell has 5 investors. Key investors include European Union, BeAble Capital, Dreavent Capital, Innvierte Economia Sostenible Sicc Sme, and Ideas de bomberossl.
A4Cell operates through Arrays For Cell Nanodevices S.L..